Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Junji Tsukagoshi

Vascular Surgery Galveston, TX Medical Doctor

NPI 1275106775 CMS profile 9089816

301 University Blvd, Galveston, TX 77555

Open in the dashboard

General payments

$8,159

76 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Junji Tsukagoshi of Galveston, TX is reported in the CMS Open Payments database as having received $8,159 across 76 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,044 31
2024 General $1,237 13
2023 General $1,528 17
2022 General $945 9
2021 General $1,404 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Junji Tsukagoshi
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Junji Tsukagoshi were reported at $3,044. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Junji Tsukagoshi Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $1,404 $471 $158–$1,421 $132
2022 $945 $725 $222–$2,183 $149
2023 $1,528 $836 $257–$2,440 $160
2024 $1,237 $909 $252–$2,619 $164
2025 $3,044 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. W. L. Gore & Associates, Inc. $2,346 13 payments
  2. Medtronic, Inc. $2,174 14 payments
  3. Shockwave Medical, Inc $558 5 payments
  4. Surmodics, Inc. $488 9 payments
  5. Endologix, Inc. $478 8 payments
  6. Cook Medical LLC $453 8 payments
  7. Boston Scientific Corporation $310 3 payments
  8. Penumbra, Inc. $283 3 payments
  9. Cardiovascular Systems Inc. $224 2 payments
  10. Silk Road Medical, Inc. $192 2 payments
  11. Other $651 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,354 70 payments
  2. Education $1,647 5 payments
  3. Grant $1,157 1 payment
Products named General payments · program years 2021–2025
  1. GORE PROPATEN Vascular Graft $1,136 3 payments
  2. ENDURANT IIS $940 12 payments
  3. GORE VIABAHN VBX Balloon Expandable Endo $618 4 payments
  4. Sublime Microcatheter, 018, 200cm, Straight $488 9 payments
  5. Pounce Thrombectomy System $488 9 payments
  6. Pounce Thrombectomy $488 9 payments
  7. Pounce Venous Thrombectomy System $488 9 payments
  8. Sublime 014 Rx PTA Balloon Dilatation Catheter $383 7 payments
  9. GORE VIABAHN Endoprosthesis $373 4 payments
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $366 3 payments
  11. Other $3,680 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for Surgery: 21

Drug cost

$114

Median for Surgery: $160

Branded share of claims

100%

Median for Surgery: 50%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 18 $114

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 200 Part D prescribers listed as Surgery; they describe a distribution and say nothing about conduct.

Records

76 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record